Zoetis Inc. (ZTS)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Zoetis Inc. keeps $28 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 32 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Zoetis beat on adjusted EPS but missed on revenue in the second fiscal quarter of 2026, reported Aug. 6, as adjusted EPS of $1.87 topped the $1.85 estimate by 1.1% and rose 6.3% from $1.76 a year ago. Revenue came in at about $2.5 billion, missing the $2.50 billion consensus by 1.3% but still rising 0.3% from about $2.46 billion a year earlier, with sales concentrated in the United States at about $1.3 billion. Gross margin held near 73% and operating margin was about 38%, while operating income reached about $937 million. Net income slipped 3.8% to about $691 million from about $718 million a year ago. Operating cash flow came in at about $1.1 billion, and Zoetis repurchased about $1.2 billion of stock while paying roughly $447 million in dividends. Consensus for the next period calls for EPS of $1.86 on revenue of $2.50 billion.
About Zoetis Inc.
Zoetis Inc. develops, makes, and sells animal health medicines and related tools, operating in the healthcare sector as a maker of animal therapeutics and diagnostics listed on the NYSE under ZTS. Its business spans veterinary pharmaceuticals, diagnostics, nutrition, and animal health technology, and generated $9.5 billion in FY2025.
Today's Snapshot
ZTS closed 0.8% above yesterday's close, while its sector was flat. At the close, ZTS was within 1.3% of its 52-week low of 68.78.
Trading Volume
Above 10d avg 4.1M
4.5M
vs S&P 500 Today
Inline with Market
+0.06%
Updated: October 2, 2026 at 20:10 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$70.69 - $97.33Sell
- RSI (14)37.47Neutral
- Stochastic %K (14, 3, 3)8.94Buy
- MACD Level (12, 26)-1.45Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.